AGY — Allergy Therapeutics Share News
0.000.00%
Last trade - 00:00
- £137.04m
- £133.36m
- £59.59m
- 15
- 9
- 100
- 32
REG - Allergy Therapeutics - Interim Results for six months ended 31 Dec 2023
AnnouncementREG - Allergy Therapeutics - Update on funding
AnnouncementREG - Allergy Therapeutics - VLP Peanut PROTECT Trial Update
AnnouncementRCS - Allergy Therapeutics - VLP Peanut PROTECT Trial Update
AnnouncementREG - Allergy Therapeutics - Appointment of Shaun Furlong to Board of Directors
AnnouncementREG - Allergy Therapeutics - Result of AGM
AnnouncementREG - Allergy Therapeutics - Half-Year Trading Update 2024
AnnouncementREG - Allergy Therapeutics - Notice of 2023 Annual General Meeting
AnnouncementREG - AIM Allergy Therapeutics - Restoration - Allergy Therapeutics plc
AnnouncementREG - Allergy Therapeutics - Publication of Annual Report and Accounts 2023
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - AIM Allergy Therapeutics - Suspension - Allergy Therapeutics plc
AnnouncementREG - Allergy Therapeutics - Amendment to existing Facility Agreement
AnnouncementREG - Allergy Therapeutics - Annual Report and Accounts Delayed
AnnouncementREG - Allergy Therapeutics - PDMR dealing and Total Voting Rights
AnnouncementREG - Allergy Therapeutics - G306 Phase III trial meets key endpoints
AnnouncementREG - Allergy Therapeutics - Update on funding
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
Announcement